ag视讯打不开-AG全讯网puma

Faculty

中文       Go Back       Search
Chengqing Ning
Research Associate Professor
0755-88018396

Education

    2011-2015 Central South University, Medicinal Chemistry, PhD

    2008-2011 Central South University, Medicinal Chemistry, MS

    2004-2008 Jiangxi University of Traditional Chinese Medicine, Pharmacy, BS

Work Experience

    2021-present, SUSTech, Research Associate Professor

    2018-2020,SUSTech, Research Assistant Professor

    2015-2017,SUSTech,  Postdoc.

Research Areas

    The major research focus of Dr. Ning is the design and synthesis of novel small molecules as anticancer and/or antiinflammatory agents through using structural analyses (such as molecular modeling), SAR studies, and biochemical assays. Identification of novel inflammatory inhibitors for the treatment of neurodegenerative disease, especially for the treatment of Alzheimer’s disease and multiple sclerosis.

Publications

  1. Shengling Xie, Pan Ren, Jieping Hou, Chengqing Ning*, Jing Xu*. Stereoselective Synthesis of the ABC Ring System of Aspterpenacids. Journal of Organic Chemistry, 2018, 83, 14152-14157.

  2. Chengqing Ning, Liumei Mo, Xuwei Chen, Wentong Tu, Jun Wu*, Shengtao Hou*, Jing Xu*. Triptolide derivatives as potential multifunctional anti-Alzheimer agents: Synthesis and structure–activity relationship studies, Bioorganic & Medicinal Chemistry Letters, 2018, 28(4): 689-693.

  3. Wentong Tu, Chengqing Ning*, Jing Xu*. Enantioselective synthesis of (-)-phaseic acid, Organic Chemistry Frontiers, 2018, 5(1): 29-31.

  4. Chengqing Ning, Cheng Lu, Liang Hu, Yanjing Bi, Lei Yao, Yujun He, Lifei Liu, Xiaoyu Liu*, Niefang Yu*. Macrocyclic compounds as anti-cancer agents: design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2. European Journal of Medicinal Chemistry. 2015, 95, 104-115.

  5. Chengqing Ning,Wenyuan Huang, Wen Wu, Cheng Lu, Yujun He, Lei Yao, Lifei Liu, Xiaohe Zhen, Xiaoyu Liu*, Niefang Yu*. Discovery of novel potent HDAC inhibitors by structure-based optimization of cinnamic hydroxamic scaffold. Letters in Drug Design & Discovery. 2015, 12, 344-350.

  6. Chengqing Ning, Yanjing Bi, Yujun He, Wenyuan Huang, Lifei Liu, Yi Li, Sihan Zhang, Xiaoyu Liu, Niefang Yu*. Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 2013, 23, 6432–6435.


天朝博彩论坛| 大玩家百家乐现金网| 20人百家乐官网桌| 皇冠足球即时比分| 不夜城百家乐官网的玩法技巧和规则 | 百家乐官网软件代理| 资兴市| 百家乐最新打法| 百家乐官网秘诀| 同城乐| 增城太阳城巧克力| 百家乐棋牌辅助| 太阳城百家乐官网手机投注| 德州扑克书籍| 百家乐盛大娱乐城城| 百家乐官网打水论坛| 百家乐官网是否有路子| bet365忠实奖金| 百家乐平注秘籍| 杨公风水24山| 澳门百家乐官网| 在线百家乐官网代理| 赢真钱的棋牌游戏| 百家乐五铺的缆是什么意思| k7百家乐最小投注| 百家乐官网冲动| 百家乐官网棋牌游戏皇冠网| 优博国际娱乐城| 盛世国际,| 二八杠论坛| 宝马百家乐的玩法技巧和规则| 百家乐游戏机分析仪| 免费百家乐官网统计软件| 基础百家乐官网规则| 百家乐官网技巧下载| 百家乐官网门户网站| 百家乐官网有好的投注法吗| 武平县| 马山县| 百家乐官网有多少局| 大发888娱乐城充值lm0|